Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
The Oncologist|March 13, 2020
Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology DrugsErin P Balogh, Andrew B Bindman, S Gail Eckhardt, et al.
Pediatric Blood & Cancer|January 6, 2015
Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumorsSrivandana Akshintala, Leigh Marcus, Katherine E Warren, et al.
Frontiers in Oncology|June 25, 2021
Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain TumorsJason Fangusaro, Maria Giuseppina Cefalo, Maria Luisa Garré, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupTabitha M Cooney, Kenneth J Cohen, Carolina V Guimaraes, et al.
Journal of Neuro-Oncology|October 5, 2011
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium studyKatherine E Warren, Sri Gururangan, J Russell Geyer, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 6, 2025
Substance Use and Pain Curriculum Innovation: Establishing a Student-Faculty Partnership for Curricular ChangeRory Vu Mather, Helen E Jack, Katherine E Warren, et al.
Cell Death & Disease|April 28, 2022
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumorsAshlyn Parkhurst, Sabrina Z Wang, Tyler R Findlay, et al.
Neuro-Oncology|June 9, 2014
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium reportJack M Su, Patrick Thompson, Adekunle Adesina, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 10, 2022
Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [<sup>18</sup>F]FDG: version 1.0Arnoldo Piccardo, Nathalie L Albert, Lise Borgwardt, et al.
The Lancet. Oncology|July 28, 2022
Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupHolly B Lindsay, Maura Massimino, Shivaram Avula, et al.
Pageof 9